The active implantable medical devices market consists of implantable devices that are electronic in nature and actively help in the diagnosis or treatment of an illness or medical condition. This includes implantable pacemakers, implantable cardioverter defibrillators, neurostimulators, implantable hearing aids and retinal implants. These devices actively monitor patient vitals and deliver therapeutic interventions like electrical stimulation or drug infusion to treat medical conditions like heart block, arrhythmias, epilepsy and hearing loss. The rising geriatric population globally is more prone to chronic illnesses resulting in increased demand for active implantable devices.
The Global Active Implantable Medical Devices Market is estimated to be valued at US$ 26.82 Billion in 2024 and is expected to exhibit a CAGR of 7.7% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the active implantable medical devices are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova, Cochlear Limited, MED-EL, Sonova Holding AG, and Nurotron Biotechnology Co. Ltd. Medtronic PLC holds the leading market share in the global active implantable medical devices market.
Growing geriatric population afflicted with chronic health conditions like cardiovascular diseases, neurological disorders is driving the demand for implantable devices globally. As per estimates, over 50% of the global population aged above 65 years will need implantable devices by 2050.
Technological advancement in areas of miniaturization, battery efficiency and wireless connectivity has enabled development of advanced active implantable devices. Next-generation neurostimulators and cardiac devices are being developed with improved therapeutic efficacy and longer battery lives.
Market Trends
The emergence of bio-inspired active implantable devices is a key trend in the market. Companies are developing neural probes, retinal implants and cochlear implants using materials and designs inspired by natural tissues for better biocompatibility. Secondly, increased adoption of remote monitoring technologies enables healthcare providers to remotely and frequently monitor patient health reducing device related complications.
Market Opportunities
Growing demand for neurological implants in developing regions presents lucrative opportunities. Asia Pacific aging population will drive strong demand for cochlear and neurostimulation implants over coming years. Secondly, emerging field of artificial organs research provides scope to develop innovative implants like artificial pancreas to treat diabetes. This expands opportunities beyond existing cardiovascular and neurological applications.
Geographical Regions with Concentrated Value in Active Implable Medical Devices Market
North America dominates the active implantable medical devices market in terms of value, accounting for a significant share. Factors such as the rising geriatric population, increasing prevalence of chronic diseases, growing healthcare spending, and rapid technological advancements are fueling market growth in the region. Within North America, the US holds the leading position due to the presence of major players and a well-developed healthcare infrastructure. Similarly, Europe is among the lucrative markets, with countries like Germany, the UK, and France holding large shares. An increasing focus on preventive healthcare and favorable reimbursement scenarios are supporting the European market. On the other hand, Asia Pacific is identified as the fastest-growing region, driven by expanding medical tourism sector, rising healthcare expenditures, and growing awareness.
The global Active Implantable Medical Devices market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
The objectives of this study are to define, segment, and project the size of the Active Implantable Medical Devices market based on company, product type, end user and key regions.This report studies the global market size of Active Implantable Medical Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Active Implantable Medical Devices in these regions.Key questions addressed by the reportWhere will all these developments take Active Implantable Medical Devicesin the mid- to long-term?What are the upcoming technological trends in the Active Implantable Medical Devicesmarket?What are the opportunities for various players that exist at present and those that are planning to enter at different stages of the value chain?How growth strategies implemented by key players will impact the growth rate of the Active Implantable Medical Devicesmarket, and who will have the undue advantage?What are the current adoption trends of the Active Implantable Medical Devicesmarket?Report Sample includes:- Table of Contents- List of Tables & Figures- Charts- Research MethodologyGet FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-active-implantable-medical-devices-2025-64This research report categorizes the global Active Implantable Medical Devices market by top players/brands, region, type and end user.
This report also studies the global Active Implantable Medical Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.The following manufacturers are covered in this report, with sales, revenue, market share for each company:MedtronicAbbott LaboratoriesBoston Scientific CorporationBIOTRONIKLivaNovaTo know more manufacturersMarket size by ProductImplantable Cardioverter DefibrillatorsVentricular Assist DevicesImplantable Heart Monitors/Insertable Loop RecordersNeurostimulatorsImplantable Hearing DevicesMarket size by End UserBradycardiaTachycardiaHeart FailureOtherMarket size by RegionNorth AmericaUnited StatesCanadaMexicoAsia-PacificChinaIndiaJapanSouth KoreaAustraliaIndonesiaSingaporeMalaysiaPhilippinesThailandVietnamEuropeGermanyFranceUKItalySpainRussiaCentral & South AmericaBrazilRest of Central & South AmericaMiddle East & AfricaGCC CountriesTurkeyEgyptSouth AfricaThe study objectives of this report are:To study and analyze the global Active Implantable Medical Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.To understand the structure of Active Implantable Medical Devices market by identifying its various subsegments.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).Focuses on the key global Active Implantable Medical Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.To project the value and sales volume of Active Implantable Medical Devices submarkets, with respect to key regions.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.In this study, the years considered to estimate the market size of Active Implantable Medical Devices are as follows:History Year: 2014-2018Base Year: 2018Estimated Year: 2019Forecast Year 2019 to 2025This report includes the estimation of market size for value (million US$) and volume (Units).
Both top-down and bottom-up approaches have been used to estimate and validate the market size of Active Implantable Medical Devices market, to estimate the size of various other dependent submarkets in the overall market.
Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research.
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.For the data information by region, company, type and application, 2018 is considered as the base year.
According to the new market research report "Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) - Global Forecast", published by MarketsandMarkets™, the active implantable medical devices market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 7.8%, to reach USD 26.75 Billion.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102063992Growth in this market can be attributed to factors such as growth in aging population, increasing prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favorable reimbursement scenario for ENT procedures in developed countries.The global active implantable medical devices market is segmented based on product and region.
Based on product, the market is segmented into implantable cardioverter defibrillators, implantable cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators, and implantable hearing devices.
Based on region, the active implantable medical devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.Browse and in-depth TOC on "Active Implantable Medical Devices Market" 151 - Tables34 - Figures 204 – PagesThe implantable cardioverter defibrillators segment accounted for the largest share of the global active implantable medical devices market.
However, the implantable hearing devices segment is expected to witness the highest growth in the next five years.
The growth of the implantable hearing devices is mainly attributed to the increasing prevalence of hearing loss across the globe and growing ENT procedures due to favorable reimbursement policies in the developed countries.North America is the largest regional segment for the active implantable medical devices market.
The large share of this regional segment can be attributed to the growth in geriatric population, increasing prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region.
Active implantable medical devices market size is set to reach $28.8 billion by 2023, growing at a CAGR of 8.0% between 2017-2023.
Technological advancements, increasing prevalence of cardiovascular diseases, increasing healthcare expenditures and rising research and development activities are the major factors driving the growth of the market.The R investments for the development of novel and innovative active implantable medical devices are increasing due to increased demand for effective implantable medical devices.
Moreover, the currently available devices require surgical implantation and replacement surgeries after every few years.
The technologically advanced implantable medical devices facilitate non-invasive procedures for the safe and effective treatment of drug-resistant neurological disorders.
Many companies in the active implantable medical devices market such as Medtronic Inc., Boston Scientific Corporation, LivaNova plc, William Demant Holding AG and Cochlear Ltd. are actively involved in the development of new and advanced active implantable devices.Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/active-implantable-medical-devices-market/report-sampleThe Asia-Pacific active implantable medical devices market is expected to grow at the fastest rate in the forecast period as compared to other regions, mainly due to growing aging population in various countries, such as India and China.
Moreover, the substantially larger base of the aging population in these Asian countries, is expected to drive the growth of the active implantable medical device market in the region.
Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled “Active Implantable Medical Devices Market by By Product (Implantable Cardioverter Defibrillators {Transvenous, Subcutaneous}, Ventricular Assist Devices, Implantable Cardiac Pacemakers, Dental Implants, Implantable Hearing Devices, Ventricular Assist Devices, Neurostimulators), End-Users (Hospitals, Ambulatory Centers, Cardiac centers, Dental Clinics, Others) Analysis and Forecast, 2019 – 2024”.
The Active Implantable Medical Devices Market report additionally states import/trade utilization, free market activity figures, cost, value, volume and gross edges.
Few of the leading organizations’ names are listed here- Boston Scientific Corporation, Cochlear Ltd., Zimmer Biomet, Smith & Nephew, Johnson & Johnson Services Inc., BIOTRONIK SE & Co. KG, LivaNova PLC, Abbott, Straumann AG, Medtronic, Integra Lifesciences Holdings Corporation, Stryker, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd., Sonova Holding AG The Global Active Implantable Medical Devices Market accounted to USD 18.9 billion in 2016 growing at a CAGR of 8.3% during the forecast period of 2017 to 2024Get Inside Scoop of the report, request for sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-active-implantable-medical-devices-market Market Definition: Global Active Implantable Medical Devices MarketImplantable medical devices are the medical device that has been intended to be totally or partially inserted, surgically or medically, into the human body using the medical intervention into a natural orifice, and it is dedicated to remain after the procedure.
Bard Inc., 3M, Dentsply Sirona, Allergan Inc., NuVasive, Inc., Cardinal Health, Inc., Microport Scientific Corporation, CONMED Corporation, Globus Medical, Inc., and MED-EL among others.
Competitive Analysis: Global Active Implantable Medical Devices Market The global active implantable medical devices market is highly fragmented and is based on new product launches and clinical results of products.
The report includes market shares of active implantable medical devices market for global, Europe, North America, Asia Pacific and South America Focal points covered in this Active Implantable Medical Devices Market reportThis Active Implantable Medical Devices Market report provides pin point analysis of the market outlook and later establishes its comparison with current patterns.
